Showing 1831-1840 of 3329 results for "".
- Merz Aesthetics Extends Partnership with North Carolina Women’s Teamhttps://modernaesthetics.com/news/merz-aesthetics-extends-partnership-with-north-carolina-womens-team/2473765/Merz Aesthetics announced its continued partnership with the Women’s National Soccer League's North Carolina Courage on Tuesday. “We are proud to continue our partnership with the NC Courage, an organization aligned in our shared values of the importance of confidence and empowerment of w
- 2025 AAD: What’s New and True for Energy-Based Deviceshttps://modernaesthetics.com/news/2025-aad-whats-new-and-true-for-energy-based-devices/2473763/At the 2025 American Academy of Dermatology (AAD) Annual Meeting, Modern Aesthetics sat in on “What’s New and What’s True for Energy-Based Devices (EBDs).” The speakers of this lecture included Suzanne L Kilmer, MD, FAAD; Arielle N.B. Kauvar, MD, FAAD; Merete Haedersdal, MD, PhD, FAAD; Jill S. Wa
- FDA Approves New HA Gels From Evolushttps://modernaesthetics.com/news/fda-approves-new-ha-gels-from-evolus/2473740/The US Food and Drug Administration has approved Evolysse™ Form and Evolysse™ Smooth injectable hyaluronic acid (HA) gels, the first two products in the Evolysse™ collection, Evolus announced. These approvals mark Evolus’ entry into the United States HA dermal filler market and solidifies the com
- Utah Surgeon's LumipenPro Enlists Archetype to Pursue EU MDR Approvalhttps://modernaesthetics.com/news/utah-surgeons-lumipenpro-enlists-archetype-to-pursue-eu-mdr-approval/2473738/Medtech innovation management consultancy Archetype has been appointed to drive the European Medical Device Regulation (EU MDR) approval process for LumipenPro™, a medical illumination device designed to enhance precision and efficiency during aesthetic surgical procedures where visibility is res
- Elevai Skincare Inc. Acquired by Bio-Aesthetics Company Carmellhttps://modernaesthetics.com/news/elevai-skincare-inc-acquired-by-bio-aesthetics-company-carmell/2473723/Carmell Corporation, a bio-aesthetics company focused on skin and hair health, announced in a press release that it entered into a definitive purchase agreement with PMGC Holdings Inc. (formerly Elevai Labs Inc.) and its wholly owned subsidiary, Elevai Skincare Inc., to acquire the assets related
- Report: Regenerative Aesthetics Exosome Market Poised for Growth Through 2031https://modernaesthetics.com/news/report-regenerative-aesthetics-exosome-market-poised-for-growth-through-2031/2473722/The global regenerative aesthetics exosome products market is projected to experience a compound annual growth rate (CAGR) of 35.5% from 2024 to 2031, according to a report from InsightAce Analytic. Exosome-based therapies with applications in skin reju
- Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc.https://modernaesthetics.com/news/elevai-labs-inc-announces-anticipated-name-change-to-pmgc-holdings-inc/2473721/Elevai Labs Inc. is changing its name to PMGC Holdings Inc., the company announced Friday. A press release also stated that PMGC Holdings Inc. plans to effectuate a strategic reorganization effective on Dec. 20. Along with the name change, the reorganization includes moving from D
- Recent Wall Street Journal Article “Belittles” Efforts of Dermatologists, Dr. Doris Dayhttps://modernaesthetics.com/news/recent-wall-street-journal-article-belittles-efforts-of-dermatologists-dr-doris-day/2473719/Modern Aesthetics Editorial Board member Doris Day, MD, FAAD, didn’t hold back when speaking out against a recent Wall Street Journal article portraying dermatology as a cushiony specialty and citing that as a reason it is gaining increasing traction from me
- The Aesthetic Society Announces Major Milestone, New Educational Opportunitieshttps://modernaesthetics.com/news/the-aesthetic-society-announces-major-milestone-new-educational-opportunities/2473711/The Aesthetic Society announced a “historic” expansion of its Global Alliance Partners program on Tuesday. The society has secured partnerships with 31 distinguished international aesthetic surgery organizations through Memorandum of Understanding (MOU) agreements. &qu
- JOYA Launches First Skin Cancer Prevention, Anti-Aging Employee Benefit Platformhttps://modernaesthetics.com/news/joya-launches-first-skin-cancer-prevention-anti-aging-employee-benefit-platform/2473695/JOYA the first employee skin health and wellness benefit platform, announced its emergence from stealth mode with $5 million in seed funding from LUX Capital, Mosaic General Partnership, Arsama Trust, and Joyance Partners. The funding will support team expansion, product developme